CellSeed Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Net Income	-910	-780	-782	140	-964
Depreciation & Amortization	2	9	5	4	4
Loss (Gain) From Sale of Assets	25	37	-	-	-
Loss (Gain) on Equity Investments	20	14	-	-	-
Other Operating Activities	-2	6	-11	-1	161
Change in Accounts Receivable	17	10	271	-294	25
Change in Inventory	1	5	7	-34	10
Change in Accounts Payable	35	-4	-23	-50	34
Change in Other Net Operating Assets	-5	3	-44	-71	-17
Operating Cash Flow	-817	-700	-577	-306	-747
Capital Expenditures	-91	-7	-13	-1	-5
Sale (Purchase) of Intangibles	-	-3	-	-	-
Investment in Securities	-	-	-119	-	-
Other Investing Activities	-19	-2	-1	-	-
Investing Cash Flow	-110	-12	-133	-1	-5
Long-Term Debt Issued	-	160	-	-	-
Net Debt Issued (Repaid)	-	160	-	-	-
Issuance of Common Stock	396	942	721	24	1,040
Financing Cash Flow	396	1,102	721	24	1,040
Foreign Exchange Rate Adjustments	-	6	-3	-8	5
Miscellaneous Cash Flow Adjustments	2	-1	-1	-1	-
Net Cash Flow	-529	395	7	-292	293
Free Cash Flow	-908	-707	-590	-307	-752
Free Cash Flow Margin	-563.98%	-355.28%	-214.54%	-29.92%	-884.71%
Free Cash Flow Per Share	-52.80	-49.88	-50.22	-26.66	-72.59
Cash Income Tax Paid	3	-1	12	2	-
Levered Free Cash Flow	-580.63	-422.38	-292.13	-359.5	-438
Unlevered Free Cash Flow	-580.63	-422.38	-292.13	-359.5	-438
Change in Working Capital	48	14	211	-449	52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.